These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22342051)

  • 1. Neonatal outcome of fetuses receiving intrauterine transfusion for severe hydrops complicated by Rhesus hemolytic disease.
    Altunyurt S; Okyay E; Saatli B; Canbahishov T; Demir N; Ozkan H
    Int J Gynaecol Obstet; 2012 May; 117(2):153-6. PubMed ID: 22342051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
    Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
    Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion.
    De Boer IP; Zeestraten EC; Lopriore E; van Kamp IL; Kanhai HH; Walther FJ
    Am J Obstet Gynecol; 2008 Jan; 198(1):54.e1-4. PubMed ID: 18166305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal intravascular transfusion for hydropic disease due to rhesus isoimmunization.
    Mesogitis S; Daskalakis G; Pilalis A; Papantoniou N; Antsaklis A
    Fetal Diagn Ther; 2005; 20(5):431-6. PubMed ID: 16113567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intrauterine transfusión in alloimmunization Rh in México 1987-2008].
    Ramírez-Robles LJ; Gómez-Partida G; Guevara-Rubio G; Velázquez-Gómez L
    Ginecol Obstet Mex; 2010 Sep; 78(9):469-77. PubMed ID: 21961364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal and neonatal outcome in severe alloimmunization managed with intrauterine transfusion: 18-year experience in a tertiary referral hospital in China.
    Pan W; Wu H; Chen J; Mo X; Wang H; Fang Q; Li Y; Huang Y
    Front Pediatr; 2023; 11():1157004. PubMed ID: 37124190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment.
    van Kamp IL; Klumper FJ; Bakkum RS; Oepkes D; Meerman RH; Scherjon SA; Kanhai HH
    Am J Obstet Gynecol; 2001 Sep; 185(3):668-73. PubMed ID: 11568796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between obstetric history and Rh(D) alloimmunization severity.
    Lobato G; Soncini CS
    Arch Gynecol Obstet; 2008 Mar; 277(3):245-8. PubMed ID: 17763861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal hematocrit decrease after repeated intravascular transfusions in alloimmunized pregnancies.
    Lobato G; Soncini CS
    Arch Gynecol Obstet; 2007 Dec; 276(6):595-9. PubMed ID: 17572904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
    Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
    Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting Intrauterine Transfusion Interval and Perinatal Outcomes in Alloimmunized Pregnancies: Time-to-Event Survival Analysis.
    Snelgrove JW; D'Souza R; Seaward PGR; Windrim R; Kelly EN; Ryan G
    Fetal Diagn Ther; 2019; 46(6):425-432. PubMed ID: 31195389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perinatal outcomes of intrauterine transfusion for foetal anaemia due to red blood cell alloimmunisation.
    Şavkli AÖ; Çetin BA; Acar Z; Özköse Z; Behram M; Çaypinar SS; Tayyar A; Yüksel MA
    J Obstet Gynaecol; 2020 Jul; 40(5):649-653. PubMed ID: 31462132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined intravascular-intraperitoneal transfusions in hydropic twins due to Rh (D) alloimmunization.
    Santolaya J; Warsof SL
    Fetal Diagn Ther; 1990; 5(2):70-5. PubMed ID: 2130831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ongoing problem: Rhesus hemolytic disease of the newborn - A decade of experience in a single centre.
    Yilmaz Yegit C; Yasa B; Ince EZ; Sarac Sivrikoz T; Coban A
    Pediatr Neonatol; 2024 Sep; 65(5):482-486. PubMed ID: 38490905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postnatal outcome in neonates with severe Rhesus c compared to rhesus D hemolytic disease.
    Rath ME; Smits-Wintjens VE; Lindenburg IT; Folman CC; Brand A; van Kamp IL; Oepkes D; Walther FJ; Lopriore E
    Transfusion; 2013 Jul; 53(7):1580-5. PubMed ID: 23113703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of severe rhesus isoimmunization by fetoscopic intravascular transfusions.
    Rodeck CH; Nicolaides KH; Warsof SL; Fysh WJ; Gamsu HR; Kemp JR
    Am J Obstet Gynecol; 1984 Nov; 150(6):769-74. PubMed ID: 6437228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose gammaglobulin (IVIG) followed by intrauterine transfusions (IUTs): a new alternative for the treatment of severe fetal hemolytic disease.
    Voto LS; Mathet ER; Zapaterio JL; Orti J; Lede RL; Margulies M
    J Perinat Med; 1997; 25(1):85-8. PubMed ID: 9085208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome predictors for maternal red blood cell alloimmunisation with anti-K and anti-D managed with intrauterine blood transfusion.
    Vlachodimitropoulou E; Garbowski M; Anne Solomon S; Abbasi N; Seaward G; Windrim R; Keunen J; Kelly E; Van Mieghem T; Shehata N; Ryan G
    Br J Haematol; 2022 Feb; 196(4):1096-1104. PubMed ID: 34862601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of haemoglobin Bart's hydrops fetalis following intrauterine transfusion in Ontario, Canada.
    Zhang HJ; Amid A; Janzen LA; Segbefia CI; Chen S; Athale U; Charpentier K; Merelles-Pulcini M; Seaward G; Kelly EN; Odame I; Waye JS; Ryan G; Kirby-Allen M
    Arch Dis Child Fetal Neonatal Ed; 2021 Jan; 106(1):51-56. PubMed ID: 32616558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal outcome after fetal anemia managed by intrauterine transfusion.
    Garabedian C; Rakza T; Thomas D; Wibaut B; Vaast P; Subtil D; Houfflin-Debarge V
    Eur J Pediatr; 2015 Nov; 174(11):1535-9. PubMed ID: 26032762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.